查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842111

全球脑肿瘤诊断市场：市场规模、份额、趋势分析（按产品、技术、癌症类型、最终用途和地区划分）、细分市场预测（2025-2033 年）

Brain Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Consumables, Software & AI Solutions), By Technique (Imaging, Molecular Diagnostics), By Cancer Type, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

脑肿瘤诊断：市场概览

预计到 2024 年，脑肿瘤诊断市场规模将达到 16.1 亿美元，到 2033 年将达到 30.6 亿美元，2025 年至 2033 年的复合年增长率为 7.60%。

全球原发性和转移性脑瘤发生率的上升以及对早期准确检测以指南复杂治疗决策的需求，推动了市场成长。

先进影像技术（MRI、PET-MRI）的日益普及、分子谱分析被纳入世卫组织和NCCN指南，以及人工智慧平台的角色日益增强，正在推动市场成长。此外，DNA甲基化谱分析报销范围的扩大和病患权益倡议力度的活性化，也加速了创新诊断解决方案的普及、标准化和需求成长。

全球脑肿瘤诊断产业代表肿瘤学和先进诊断交叉领域的高价值、高需求机会。虽然脑瘤仅占所有癌症的2%，但它是全球最令人痛苦的恶性肿瘤之一，也是导致癌症患者寿命损失的第四大常见癌症。治疗费用极为高昂，患者通常需要终身接受监测和追踪检查。值得注意的是，直到最近，脑肿瘤一直是儿童和青少年癌症相关死亡的主要原因，这凸显了尚未满足的医疗需求。

从市场角度来看，这种独特的疾病负担转化为对诊断的持续需求。临床现实是，脑肿瘤的治疗创新落后于其他癌症，因此，患者管理高度依赖准确、可重复且先进的诊断方法。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析
  • 新冠疫情影响分析

第四章：依技术进行业务分析

  • 脑肿瘤诊断市场：按技术分類的趋势分析（2024 年和 2033 年）
  • 影像诊断
    • 诊断影像市场（2021-2033）
    • MRI
    • 电脑断层扫描（CT）
    • 宠物
    • 单光子发射电脑断层扫描（SPECT）
  • 组织取样/切片检查
    • 组织取样/切片检查市场（2021-2033）
  • 分子诊断
    • 分子诊断市场（2021-2033）
  • 其他的
    • 其他市场（2021-2033 年）

第五章：依产品进行业务分析

  • 脑肿瘤诊断市场：按产品分類的趋势分析（2024 年和 2033 年）
  • 设备和系统
    • 设备与系统市场（2021-2033）
  • 试剂和耗材
    • 试剂和耗材市场（2021-2033）
  • 软体和人工智慧解决方案
    • 软体和人工智慧解决方案市场（2021-2033）

第六章：依癌症类型进行业务分析

  • 脑肿瘤诊断市场：按癌症类型分類的趋势分析（2024 年和 2033 年）
  • 胶质瘤
    • 胶质瘤市场（2021-2033）
  • 脑膜瘤
    • 脑膜瘤市场（2021-2033）
  • 脑下垂体瘤
    • 脑下垂体瘤市场（2021-2033）
  • 其他的
    • 其他市场（2021-2033 年）

第七章 依最终用途进行业务分析

  • 脑肿瘤诊断市场：按最终用途分類的变化分析（2024 年和 2033 年）
  • 医院
    • 医院市场（2021-2033 年）
  • 肿瘤治疗中心
    • 肿瘤治疗中心市场（2021-2033）
  • 其他的
    • 其他市场（2021-2033 年）

第八章：区域商业分析

  • 市场概览：按地区划分
  • 北美洲
    • 北美脑肿瘤诊断市场（2021-2033）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲脑肿瘤诊断市场（2021-2033）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区脑肿瘤诊断市场（2021-2033）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲脑肿瘤诊断市场（2021-2033）
    • 主要国家的趋势
    • 法律规范
    • 竞争场景
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲脑肿瘤诊断市场（2021-2033）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司分类
  • 策略规划
    • 获得
    • 合作
    • 新平台推出
    • 其他的
  • 公司简介/上市公司
    • Hologic Inc.
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Thermo Fisher Scientific
    • Illumina, Inc.
    • Agilent Technologies
    • Bio-Rad Laboratories
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-4-68040-734-7

Brain Cancer Diagnostics Market Summary

The Brain cancer diagnostics market size was valued at USD 1.61 billion in 2024 and is expected to reach USD 3.06 billion by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The market growth is driven by the rising global incidence of primary and metastatic brain tumors, coupled with the need for early and accurate detection to guide complex treatment decisions.

Growing adoption of advanced imaging modalities (MRI, PET-MRI), integration of molecular profiling into WHO and NCCN guidelines, and the increasing role of AI-enabled platforms are fueling market growth. In addition, expanding reimbursement for DNA methylation profiling and heightened patient advocacy initiatives are accelerating access, standardization, and demand for innovative diagnostic solutions.

The global brain cancer diagnostics industry represents a high-value, high-need opportunity at the intersection of oncology and advanced diagnostics. Although brain cancers account for just ~2% of all cancers, they rank among the most burdensome malignancies worldwide, driving the fourth highest number of years of life lost across cancers. Treatment costs are exceptionally high, and patients typically undergo lifelong surveillance and follow-up scans. Importantly, until recently, brain tumors were the leading cause of cancer-related death among pediatric and young adult patients, underscoring the unmet medical need.

From a market perspective, this unique disease burden translates into sustained demand for diagnostics. The clinical reality is that therapeutic innovation in brain tumors has lagged behind other cancers; as a result, patient management is disproportionately dependent on accurate, repeated, and advanced diagnostics.

Global Brain Cancer Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the brain cancer diagnostics market report based on cancer type, product, technique, end use, and region:

  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Imaging
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT) Scan
    • PET
    • Single-Photon Emission Computed Tomography (SPECT) Scan
  • Tissue Sampling / Biopsy
  • Molecular Diagnostics
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments & Systems
  • Reagents & Consumables
  • Software & AI Solutions
  • Cancer Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Gliomas
  • Meningiomas
  • Pituitary Tumors
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Oncology Treatment Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Cancer Type and Product Snapshot
  • 2.3. Technique and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Technique Business Analysis

  • 4.1. Brain Cancer Diagnostics Market: Technique Movement Analysis, 2024 & 2033
  • 4.2. Imaging
    • 4.2.1. Imaging Market, 2021 - 2033 (USD Million)
    • 4.2.2. MRI
      • 4.2.2.1. MRI market, 2021 - 2033 (USD million)
    • 4.2.3. Computed Tomography (CT) Scan
      • 4.2.3.1. Computed Tomography (CT) Scan market, 2021 - 2033 (USD million)
    • 4.2.4. PET
      • 4.2.4.1. PET market, 2021 - 2033 (USD million)
    • 4.2.5. Single-Photon Emission Computed Tomography (SPECT) Scan
      • 4.2.5.1. Single-Photon Emission Computed Tomography (SPECT) Scan market, 2021 - 2033 (USD million)
  • 4.3. Tissue Sampling / Biopsy
    • 4.3.1. Tissue Sampling / Biopsy Market, 2021 - 2033 (USD Million)
  • 4.4. Molecular Diagnostics
    • 4.4.1. Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Brain Cancer Diagnostics Market: Product Movement Analysis, 2024 & 2033
  • 5.2. Instruments & Systems
    • 5.2.1. Instruments & Systems Market, 2021 - 2033 (USD Million)
  • 5.3. Reagents & Consumables
    • 5.3.1. Reagents & Consumables market, 2021 - 2033 (USD million)
  • 5.4. Software & AI Solutions
    • 5.4.1. Software & AI Solutions market, 2021 - 2033 (USD million)

Chapter 6. Cancer Type Business Analysis

  • 6.1. Brain Cancer Diagnostics Market: Cancer Type Movement Analysis, 2024 & 2033
  • 6.2. Gliomas
    • 6.2.1. Gliomas Market, 2021 - 2033 (USD Million)
  • 6.3. Meningiomas
    • 6.3.1. Meningiomas market, 2021 - 2033 (USD million)
  • 6.4. Pituitary Tumors
    • 6.4.1. Pituitary Tumors market, 2021 - 2033 (USD million)
  • 6.5. Others
    • 6.5.1. Others market, 2021 - 2033 (USD million)

Chapter 7. End Use Business Analysis

  • 7.1. Brain Cancer Diagnostics Market: End Use Movement Analysis, 2024 & 2033
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 7.3. Oncology Treatment Centers
    • 7.3.1. Oncology Treatment Centers Market, 2021 - 2033 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.2. Key Country Dynamics
    • 8.5.3. Regulatory Framework
    • 8.5.4. Competitive Scenario
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.5.2. Key Country Dynamics
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Competitive Scenario
    • 8.5.6. Argentina
      • 8.5.6.1. Argentina Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.6.2. Key Country Dynamics
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Brain Cancer Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. Hologic Inc.
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Platform Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. GE Healthcare
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Platform Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Siemens Healthineers
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Platform Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Philips Healthcare
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Platform Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Thermo Fisher Scientific
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Platform Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Illumina, Inc.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Platform Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Agilent Technologies
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Platform Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Bio-Rad Laboratories
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Platform Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Abbott Laboratories
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Platform Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. F. Hoffmann-La Roche Ltd.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Platform Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 4 Global Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 6 Global Brain Cancer Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Brain Cancer Diagnostics Market, by Region, 2021 - 2033 (USD Million)
  • Table 8 North America Brain Cancer Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 10 North America Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 11 North America Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 12 North America OTC U.S Brain Cancer Diagnostics Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 14 U.S Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 15 U.S Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 16 U.S Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 18 Canada Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Canada Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 20 Canada Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 22 Mexico Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Mexico Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 24 Mexico Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Brain Cancer Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 27 Europe Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 28 Europe Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 29 Europe Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 31 UK Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 32 UK Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 33 UK Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 35 Germany Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 Germany Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 37 Germany Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 38 France Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 39 France Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 40 France Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 41 France Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 43 Italy Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Italy Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 45 Italy Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 47 Spain Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Spain Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 49 Spain Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 50 Norway Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 51 Norway Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Norway Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 53 Norway Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 55 Sweden Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Sweden Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 57 Sweden Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 59 Denmark Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Denmark Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 61 Denmark Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Brain Cancer Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 68 Japan Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 69 Japan Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 70 Japan Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 71 China Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 72 China Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 73 China Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 74 China Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 75 India Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 76 India Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 77 India Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 78 India Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 80 Australia Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 81 Australia Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 82 Australia Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 84 South Korea Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 85 South Korea Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 86 South Korea Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 87 Thailand Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 88 Thailand Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 89 Thailand Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 90 Thailand Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Brain Cancer Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 93 Latin America Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 94 Latin America Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 95 Latin America Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 97 Brazil Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 98 Brazil Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 99 Brazil Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 101 Argentina Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 102 Argentina Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 103 Argentina Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East Africa Brain Cancer Diagnostics Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East Africa Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 106 Middle East Africa Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 107 Middle East Africa Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 108 Middle East Africa Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 110 South Africa Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 111 South Africa Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 112 South Africa Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 118 UAE Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 119 UAE Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 120 UAE Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Brain Cancer Diagnostics Market, by Cancer Type, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Brain Cancer Diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Brain Cancer Diagnostics Market, by Technique, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Brain Cancer Diagnostics Market by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping, 2024
  • Fig. 15 Global Brain Cancer Diagnostics Market: Technique Movement Analysis
  • Fig. 16 Global Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Global MRI Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Global Computed Tomography (CT) Scan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Global PET Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Global Single-Photon Emission Computed Tomography (SPECT) Scan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Global Tissue Sampling / Biopsy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Global Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Global Other Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Global Brain Cancer Diagnostics Market: Product Movement Analysis
  • Fig. 25 Global Instruments & Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Global Reagents & Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Global Software & AI Solutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Global Brain Cancer Diagnostics Market: Cancer Type Movement Analysis
  • Fig. 29 Global Gliomas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Global Meningiomas Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Global Pituitary Tumors Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Global Brain Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 34 Global Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Global Oncology Treatment Centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 Regional Outlook, 2024 & 2033
  • Fig. 39 Global Brain Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 40 North America Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 U.S Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Canada Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Germany Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 UK Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 France Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Italy Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Spain Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Norway Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 China Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 India Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Argentina Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Middle East And Africa Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Saudi Arabia Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 UAE Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Kuwait Brain Cancer Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)